← All trials
NCT04857047
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2021
- Primary completion
- Jun 15, 2021
- Completion date
- Jun 28, 2021
- First posted
- Apr 23, 2021
- Last posted
- Aug 18, 2021
- Enrollment
- 27
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Boryung Pharmaceutical CompanyLead sponsor
- Inha UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.